BRIEF-Harmony Biosciences Q2 Net Income USD 75.431 Million
Reuters2026/08/04 11:31Aug 04 (Reuters) - Harmony Biosciences Q2 gross profit USD 198.082 million.
- Q2 product revenue USD 261.28 million vs. IBES estimate USD 250.2 million
- Q2 operating income USD 89.316 million
- Q2 pretax profit USD 93.265 million vs. IBES estimate USD 74.3 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Xenia Hôtellerie Solution announces extraordinary shareholder meeting
Community Reacts As Pundit Claims XRP Will Be Priced At $2,953 By Q2 2027
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Crypto prices
More
